Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer

由 Kunzmann, Volker, Herrmann, Ken, Bluemel, Christina, Kapp, Markus, Hartlapp, Ingo, Steger, Ulrich
出版 2014

(68)Gallium- and (90)Yttrium-/(177)Lutetium: “theranostic twins” for diagnosis and treatment of NETs

由 Werner, Rudolf A., Bluemel, Christina, Allen-Auerbach, Martin S., Higuchi, Takahiro, Herrmann, Ken
發表在 Ann Nucl Med (2014)

A case report of a solitary pancreatic metastasis of an adrenocortical carcinoma

由 Baur, Johannes, Schedelbeck, Ulla, Pulzer, Alina, Bluemel, Christina, Wild, Vanessa, Fassnacht, Martin, Steger, U.
發表在 BMC Surg (2015)

DNA damage in blood lymphocytes in patients after (177)Lu peptide receptor radionuclide therapy

由 Eberlein, Uta, Nowak, Carina, Bluemel, Christina, Buck, Andreas Konrad, Werner, Rudolf Alexander, Scherthan, Harry, Lassmann, Michael
發表在 Eur J Nucl Med Mol Imaging (2015)

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

由 Lapa, Constantin, Werner, Rudolf A, Bluemel, Christina, Lückerath, Katharina, Schirbel, Andreas, Strate, Alexander, Buck, Andreas K, Herrmann, Ken
發表在 EJNMMI Res (2014)

The impact of (177)Lu-octreotide therapy on (99m)Tc-MAG3 clearance is not predictive for late nephropathy

由 Werner, Rudolf A., Beykan, Seval, Higuchi, Takahiro, Lückerath, Katharina, Weich, Alexander, Scheurlen, Michael, Bluemel, Christina, Herrmann, Ken, Buck, Andreas K., Lassmann, Michael, Lapa, Constantin, Hänscheid, Heribert
發表在 Oncotarget (2016)

Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy

由 Bluemel, Christina, Linke, Fraenze, Herrmann, Ken, Simunovic, Iva, Eiber, Matthias, Kestler, Christian, Buck, Andreas K., Schirbel, Andreas, Bley, Thorsten A., Wester, Hans-Juergen, Vergho, Daniel, Becker, Axel
發表在 EJNMMI Res (2016)

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

由 Lapa, Constantin, Werner, Rudolf A, Bluemel, Christina, Lueckerath, Katharina, Muegge, Dirk O, Strate, Alexander, Haenscheid, Heribert, Schirbel, Andreas, Allen-Auerbach, Martin S, Bundschuh, Ralph A, Buck, Andreas K, Herrmann, Ken
發表在 EJNMMI Res (2014)

(68)Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients

由 Fendler, Wolfgang Peter, Barrio, Martin, Spick, Claudio, Allen-Auerbach, Martin, Ambrosini, Valentina, Benz, Matthias, Bluemel, Christina, Grewal, Ravinder Kaur, Lapa, Constantin, Miederer, Matthias, Nicolas, Guillaume, Schuster, Tibor, Czernin, Johannes, Herrmann, Ken
發表在 J Nucl Med (2017)

Biodistribution and Radiation Dosimetry for a Probe Targeting Prostate-Specific Membrane Antigen for Imaging and Therapy

由 Herrmann, Ken, Bluemel, Christina, Weineisen, Martina, Schottelius, Margret, Wester, Hans-Jürgen, Czernin, Johannes, Eberlein, Uta, Beykan, Seval, Lapa, Constantin, Riedmiller, Hubertus, Krebs, Markus, Kropf, Saskia, Schirbel, Andreas, Buck, Andreas K., Lassmann, Michael
發表在 J Nucl Med (2015)

(68)Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative (18)F-Choline-PET/CT

由 Bluemel, Christina, Krebs, Markus, Polat, Bülent, Linke, Fränze, Eiber, Matthias, Samnick, Samuel, Lapa, Constantin, Lassmann, Michael, Riedmiller, Hubertus, Czernin, Johannes, Rubello, Domenico, Bley, Thorsten, Kropf, Saskia, Wester, Hans-Juergen, Buck, Andreas K., Herrmann, Ken
發表在 Clin Nucl Med (2016)